Deploying wearable devices in global clinical studies offer the promise of better, more cost-efficient data for clinical trial sponsors, but what about the infrastructure behind the massive volumes of data? Unreliable cell network coverage in certain markets? Wearables’ ability to collect reliable, validated endpoint data?
I had a lovely chat with The Telegraph's Iain Withers for an interesting article on mHealth technology to answer a pressing question: "The modern pharmaceutical age has granted doctors a panoply of drugs to help with a variety of conditions, but how to ensure the patient takes them?"
I have a short quote in the article, but I have some additional thoughts on where we are and where we are headed.